Alcon Future Growth

Future criteria checks 3/6

Alcon is forecast to grow earnings and revenue by 10.5% and 5.8% per annum respectively. EPS is expected to grow by 9.5% per annum. Return on equity is forecast to be 8.4% in 3 years.

Key information

10.5%

Earnings growth rate

9.5%

EPS growth rate

Medical Equipment earnings growth	15.7%
Revenue growth rate	5.8%
Future return on equity	8.4%
Analyst coverage	Good
Last updated	21 Apr 2024

Recent future growth updates

Results: Alcon Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Mar 01

Recent updates

Alcon Inc.'s (VTX:ALC) Shareholders Might Be Looking For Exit

Apr 03

Here's Why Alcon (VTX:ALC) Has Caught The Eye Of Investors

Mar 21

Results: Alcon Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Mar 01

There's Been No Shortage Of Growth Recently For Alcon's (VTX:ALC) Returns On Capital

Feb 13

Does Alcon (VTX:ALC) Have A Healthy Balance Sheet?

Dec 28

We Like These Underlying Return On Capital Trends At Alcon (VTX:ALC)

Oct 26

Does Alcon (VTX:ALC) Have A Healthy Balance Sheet?

Sep 15

Alcon's (VTX:ALC) Robust Earnings Are Supported By Other Strong Factors

Aug 24

Is Alcon (VTX:ALC) A Risky Investment?

Jun 11

Alcon Inc. (VTX:ALC) On The Verge Of Breaking Even

May 16

Analyst Estimates: Here's What Brokers Think Of Alcon Inc. (VTX:ALC) After Its Annual Report

Feb 25

Is Alcon (VTX:ALC) A Risky Investment?

Feb 11

Earnings and Revenue Growth Forecasts

SWX:ALC - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	11,325	1,403	1,866	2,527	14
12/31/2025	10,650	1,255	1,556	2,365	20
12/31/2024	10,003	936	1,318	2,122	21
12/31/2023	9,455	974	535	1,388	N/A
9/30/2023	9,274	450	525	1,282	N/A
6/30/2023	9,085	362	317	1,157	N/A
3/31/2023	8,880	341	480	1,236	N/A
12/31/2022	8,717	335	-13	1,217	N/A
9/30/2022	8,695	571	-61	1,259	N/A
6/30/2022	8,657	457	-17	1,273	N/A
3/31/2022	8,550	460	-406	1,255	N/A
12/31/2021	8,291	376	165	1,345	N/A
9/30/2021	8,082	332	322	1,397	N/A
6/30/2021	7,818	183	307	1,307	N/A
3/31/2021	6,922	-390	364	949	N/A
12/31/2020	6,833	-531	256	823	N/A
9/30/2020	6,806	-717	132	730	N/A
6/30/2020	6,836	-636	62	677	N/A
3/31/2020	7,525	-604	275	920	N/A
12/31/2019	7,508	-656	244	920	N/A
9/30/2019	7,386	-638	134	800	N/A
6/30/2019	7,280	-779	178	886	N/A
3/31/2019	7,177	-362	178	893	N/A
12/31/2018	7,153	-227	428	1,140	N/A
9/30/2018	7,123	175	697	1,375	N/A
12/31/2017	6,792	256	722	1,218	N/A
12/31/2016	6,596	-170	N/A	1,245	N/A
12/31/2015	6,776	308	N/A	1,370	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ALC's forecast earnings growth (10.5% per year) is above the savings rate (0.1%).

Earnings vs Market: ALC's earnings (10.5% per year) are forecast to grow faster than the Swiss market (7.9% per year).

High Growth Earnings: ALC's earnings are forecast to grow, but not significantly.

Revenue vs Market: ALC's revenue (5.8% per year) is forecast to grow faster than the Swiss market (4.3% per year).

High Growth Revenue: ALC's revenue (5.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ALC's Return on Equity is forecast to be low in 3 years time (8.4%).

Discover growth companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Alcon Future Growth

Future criteria checks 3/6

Key information

Recent future growth updates

Results: Alcon Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Alcon Inc. Revises Earnings Guidance for the Full Year 2023

Alcon Inc. Raises Earnings Guidance for the Full Year 2023

Alcon Inc. Provides Earnings Guidance for the Year 2023

Alcon Inc. Updates Earnings Guidance for the Year 2022

Alcon Inc. Revises Revenue Guidance for 2022

Recent updates

Dividend of CHF0.24 announced

Alcon Inc.'s (VTX:ALC) Shareholders Might Be Looking For Exit

Alcon Announces Management Changes

Here's Why Alcon (VTX:ALC) Has Caught The Eye Of Investors

Alcon Inc. Launches Clareon Presbyopia Correcting IOLs in India

President of North America notifies of intention to sell stock

Results: Alcon Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Alcon Inc. Proposes Dividend for the Year 2023

Full year 2023 earnings: EPS exceeds analyst expectations

Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet

Alcon Announces Positive Topline Results from Phase 3 Comet Trials of AR-15512, A Novel Topical Drug Candidate for Dry Eye

Alcon Inc.'s (VTX:ALC) Business Is Yet to Catch Up With Its Share Price

Returns On Capital Are Showing Encouraging Signs At Alcon (VTX:ALC)

Alcon Inc., Annual General Meeting, May 08, 2024

Alcon Inc. Revises Earnings Guidance for the Full Year 2023

Third quarter 2023 earnings: EPS exceeds analyst expectations

Calculating The Fair Value Of Alcon Inc. (VTX:ALC)

Alcon Inc. Showcases Cloud-Based Planning and World-Class Digital Technologies During AAO 2023

Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet

Alcon Launches Total30 Multifocal Contact Lenses for Patients with Presbyopia

Alcon (VTX:ALC) Might Have The Makings Of A Multi-Bagger

Alcon Inc. Raises Earnings Guidance for the Full Year 2023

Second quarter 2023 earnings released: EPS: US$0.34 (vs US$0.30 in 2Q 2022)

A Look At The Fair Value Of Alcon Inc. (VTX:ALC)

Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet

Head of Corporate Development notifies of intention to sell stock

Investors Will Want Alcon's (VTX:ALC) Growth In ROCE To Persist

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Alcon Inc. Provides Earnings Guidance for the Year 2023

Alcon Announces Results from a New Study Presented at the American Society of Cataract and Refractive Surgery Annual Meeting

Alcon Inc. Approves Dividend

Upcoming dividend of CHF0.21 per share at 0.3% yield

Does Alcon (VTX:ALC) Have A Healthy Balance Sheet?

Full year 2022 earnings: EPS misses analyst expectations

Now 21% undervalued

Alcon Inc. Announces Settlement of Litigation Related to Femtosecond Laser Assisted Cataract Surgery Devices

Alcon Launches New Total Toric Lenses for Astigmatic Patients

Here's Why Alcon (VTX:ALC) Has Caught The Eye Of Investors

Returns Are Gaining Momentum At Alcon (VTX:ALC)

Alcon Inc., Annual General Meeting, May 05, 2023

Alcon Introduces a Premium, Reusable Toric Lens with Launch of TOTAL30 for Astigmatism

Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet

Now 20% undervalued

Alcon Inc. Updates Earnings Guidance for the Year 2022

Insufficient new directors

Alcon Inc. Revises Revenue Guidance for 2022

Do Alcon's (VTX:ALC) Earnings Warrant Your Attention?

Alcon Completes Availability of Clareon Portfolio with Clareon Toric During AAO 2022

Alcon's (VTX:ALC) Returns On Capital Are Heading Higher

We Think Alcon (VTX:ALC) Can Stay On Top Of Its Debt

With Alcon Inc. (VTX:ALC) It Looks Like You'll Get What You Pay For

Alcon Inc. (SWX:ALC) entered into a definitive merger agreement to acquire Aerie Pharmaceuticals, Inc. (NasdaqGM:AERI) for approximately $770 million.

Consensus forecasts updated

Second quarter 2022 earnings: EPS exceeds analyst expectations

Alcon Inc. Revises Revenue Guidance for 2022

These 4 Measures Indicate That Alcon (VTX:ALC) Is Using Debt Reasonably Well

Alcon Inc. (SWX:ALC) acquired EYSUVIS® from Kala Pharmaceuticals, Inc. (NasdaqGS:KALA) for $60 million.

Alcon (VTX:ALC) Is Experiencing Growth In Returns On Capital

Alcon Inc. Reaffirms Earnings Guidance for the Fiscal 2022

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Alcon Inc. Declares Dividend for 2021

Insufficient new directors

Alcon Announces Key Data to Be Presented at This Year’s American Society of Cataract and Refractive Surgery Meeting on its SMART Solutions for Cataract Surgery

Alcon Inc. Announces Launch of Clareon Portfolio in the U.S

Consensus EPS estimates increase by 12%

Full year 2021 earnings: EPS exceeds analyst expectations

Alcon Inc. Proposes Dividend

There's Been No Shortage Of Growth Recently For Alcon's (VTX:ALC) Returns On Capital

Alcon Inc. Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe